EFSPI Strategic Objectives 2016-2018

  1. Represent the association members of EFSPI and provide a united and respected voice on key scientific, regulatory and statistical issues in drug development
    • Develop program of scientific meetings and partner with association members to provide opportunities to discuss and align on key scientific, regulatory and statistical issues (responsible: Scientific Chair)
    • Utilise EFSPI Statistics Leaders forum to discuss and align on emerging statistical areas and identify priorities and opportunities for EFSPI to lead/promote these areas in the health care environment (responsible: Statistics Leader Chair)
  2. Set and promote professional standards in Europe for the development, application, understanding and communication of statistics in drug development and related fields
    • Write 1-2 professional position papers / best practice papers per year in collaboration with representatives from association members and SIGs (responsible: Council representatives, SIG Chairs)
    • Hold Annual EFSPI meeting, produce monthly newsletters, and disseminate relevant information (responsible: Communication Office, Scientific Chair)
    • Foster collaboration between local organizations to promote relationships and share best practices (responsible: EFSPI president)
  3. Enhance the profile of EFSPI and strengthen alliances and collaborations with other bodies within Europe and other regions

    Seeking opportunities to collaborate with:

    • the EMA Biostatistics Working Group and regulatory statisticians (responsible: Regulatory Chair)
    • the EUneHTA Network (responsible: HTA SIG)
    • International statistical community and associations important to the Special Interest Groups (SIGs)(responsible: SIG Chair)
    • the European Federation of Pharmaceutical Industry Associations (EFPIA) (responsible: President, Scientific Chair)

    On the following key activities:

    • Methodology/research and good research practice papers/reports
    • Training opportunities, scientific meetings and discussing mutual areas of interest
    • Development and review of regulatory and payer guidelines
    • Professional development and successfully adapting to changes in the environment